NDC product
Hemorrhoidal cocoa butter
NDC 13709-323 · NeilMed Pharmaceuticals Inc.
Key facts
| Product NDC | 13709-323 |
|---|---|
| Proprietary name | Hemorrhoidal cocoa butter |
| Nonproprietary name | Hemorrhoidal |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, COCOA BUTTER |
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
| Labeler | NeilMed Pharmaceuticals Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Aug 24, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: